GVHD Therapy Based on Risk Assessment

Track: BMT CTN Coordinators Meeting
Wednesday, February 11, 2015, 12:55 PM-1:25 PM
Harbor Ballroom DEF (Manchester Grand Hyatt)
John Levine, MD, MS , Pediatric Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
Disclosures:
J. Levine, University of Michigan, Professor: Financial Benefit and/or patents